Text size Maddie Meyer / Getty Images Analysts begin to speculate on which of the Covid-19 vaccines could win, after scientists working on two of the most advanced vaccine programs made presentations about their progress at a meeting of a key advisory committee at the Centers for Disease Control and …
Read More »Pandemic PC boom drives HP sales $ 1 billion higher than expected; stock 5%
Continuing the stagnant revenue streak, HP Inc. shares initially jumped 5% in trading after hours Thursday after reporting fiscal third-quarter sales that surpassed Wall Street’s $ 1 billion estimates, due to a pandemic. affected boom in sales of personal computers. HP HPQ, + 2.01% reported net income of $ 734 …
Read More »The COVID-19 vaccine candidates from Moderna and Pfizer need ultra-low temperatures, raising questions about storage, distribution
The COVID-19 vaccine candidates developed by Moderna Inc. and BioNTech and Pfizer Inc. will require strict standards for cooling, and that may hinder how they are distributed to the hundreds of millions of Americans who expect to receive them. Shares of Modern MRNA, -3.54% were 3.6% lower in trading on …
Read More »Moderna’s Covid-19 vaccine shows promise in older adults. His supply climbs.
Text size Dreamstime Older adults who participated in Moderna‘s Phase 1 trial of its Covid-19 vaccine responded just as well as younger adults, according to data, the biotech company presented Wednesday morning to a key Centers for Disease Control and Prevention Advisory panel. This is important because Covid-19 is not …
Read More »FDA grants emergency use status to Abbott’s $ 5 COVID-19 rapid antigen test
The U.S. Food and Drug Administration has granted emergency authorization to Abbott Laboratories for a $ 5 rapid response COVID-19 antigen test that is about the size of a credit card. The inexpensive, rapid-response test could be administered in an office of a physician as a school nurse and uses …
Read More »